<scp>DKK1</scp> drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with <scp>anti‐DKK1</scp> therapeutic <scp>DKN</scp> ‐01
Edward J. Jarman(Western General Hospital), Luke Boulter(Edinburgh Cancer Research), Stephanie MacMaster(Institute of Genetics and Cancer), David H. Wilson(University of Zimbabwe), Konstantinos Gournopanos(Institute of Genetics and Cancer), Michael H. Kagey, Panagiota Tsokkou(Medical University of Vienna), Marta Horcas‐Lopez(MRC Centre for Reproductive Health), Jeffrey W. Pollard(MRC Centre for Reproductive Health), Scott H. Waddell(Edinburgh Cancer Research), William Cambridge(Institute of Genetics and Cancer), Walter Newman(Ensemble Therapeutics (United States)), Minn E Ng(Institute of Genetics and Cancer), Kamila Irena Musialik(Institute of Genetics and Cancer), Daniel Soong(MRC Centre for Reproductive Health)
Cited by 20
Related Papers
Microenvironmental regulation of metastasis
|Nature reviews. Cancer|2008|3.7k
Immune cell promotion of metastasis
|Nature reviews. Immunology|2015|1.2k
Trophic macrophages in development and disease
|Nature reviews. Immunology|2009|1.2k
Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets
|Cancer Cell|2019|948
Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids
|Cell stem cell|2021|311